These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 18663559)
1. Taurine in plasma and CSF: a study in healthy male volunteers. Samuelsson M; Dahl ML; Gupta RC; Nordin C Amino Acids; 2009 Mar; 36(3):529-33. PubMed ID: 18663559 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers. Preskorn S; Patroneva A; Silman H; Jiang Q; Isler JA; Burczynski ME; Ahmed S; Paul J; Nichols AI J Clin Psychopharmacol; 2009 Feb; 29(1):39-43. PubMed ID: 19142106 [TBL] [Abstract][Full Text] [Related]
3. Tramadol as a new probe for cytochrome P450 2D6 phenotyping: a population study. Pedersen RS; Damkier P; Brosen K Clin Pharmacol Ther; 2005 Jun; 77(6):458-67. PubMed ID: 15961977 [TBL] [Abstract][Full Text] [Related]
4. Acamprosate determinations in plasma and cerebrospinal fluid after multiple dosing measured by liquid chromatography-mass spectroscopy: a pharmacokinetic study in healthy volunteers. Hammarberg A; Beck O; Eksborg S; Jayaram-Lindström N; Lindefeldt A; Andersson M; Brundin L; Reid MS; Franck J Ther Drug Monit; 2010 Aug; 32(4):489-96. PubMed ID: 20592646 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of novel atrial-selective antiarrhythmic agent vernakalant hydrochloride injection (RSD1235): influence of CYP2D6 expression and other factors. Mao ZL; Wheeler JJ; Clohs L; Beatch GN; Keirns J J Clin Pharmacol; 2009 Jan; 49(1):17-29. PubMed ID: 18927241 [TBL] [Abstract][Full Text] [Related]
6. CSF taurine level is influenced by plasma cholesterol and the CYP2D6 phenotype. Nordin C; Dahl ML; Eklundh T; Eriksson M; Sjöberg S Eur Neuropsychopharmacol; 2003 Oct; 13(5):333-5. PubMed ID: 12957331 [TBL] [Abstract][Full Text] [Related]
7. Taurine kinetics assessed using [1,2-13C2]taurine in healthy adult humans. Rakotoambinina B; Marks L; Badran AM; Igliki F; Thuillier F; Crenn P; Messing B; Darmaun D Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E255-62. PubMed ID: 15010336 [TBL] [Abstract][Full Text] [Related]
8. CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients. Halling J; Weihe P; Brosen K Ther Drug Monit; 2008 Jun; 30(3):271-5. PubMed ID: 18520597 [TBL] [Abstract][Full Text] [Related]
9. Changes in plasma concentration of taurine in stroke. Ghandforoush-Sattari M; Mashayekhi SO; Nemati M; Ayromlou H Neurosci Lett; 2011 Jun; 496(3):172-5. PubMed ID: 21514364 [TBL] [Abstract][Full Text] [Related]
10. Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene. Arneth B; Shams M; Hiemke C; Härtter S Clin Biochem; 2009 Aug; 42(12):1282-90. PubMed ID: 19393232 [TBL] [Abstract][Full Text] [Related]
12. Glutathione in the blood and cerebrospinal fluid: a study in healthy male volunteers. Samuelsson M; Vainikka L; Ollinger K Neuropeptides; 2011 Aug; 45(4):287-92. PubMed ID: 21708405 [TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker users. Bijl MJ; Visser LE; van Schaik RH; Kors JA; Witteman JC; Hofman A; Vulto AG; van Gelder T; Stricker BH Clin Pharmacol Ther; 2009 Jan; 85(1):45-50. PubMed ID: 18784654 [TBL] [Abstract][Full Text] [Related]
14. Effect of desvenlafaxine on the cytochrome P450 2D6 enzyme system. Preskorn SH; Nichols AI; Paul J; Patroneva AL; Helzner EC; Guico-Pabia CJ J Psychiatr Pract; 2008 Nov; 14(6):368-78. PubMed ID: 19057238 [TBL] [Abstract][Full Text] [Related]
15. [CYP 2D6 activity profile among patients with depression]. Bidziński A; Koszewska I; Turzyńska D; Kalinowski A; Swiecicki L; Dabrowski M; Torbiński J; Burna-Drazkowic E; Fornal S; Gradzka D; Namysłowska M; Puzyński S; Płaźnik A Psychiatr Pol; 2004; 38(6):1085-92. PubMed ID: 15779672 [TBL] [Abstract][Full Text] [Related]
16. Developmental changes in human liver CYP2D6 expression. Stevens JC; Marsh SA; Zaya MJ; Regina KJ; Divakaran K; Le M; Hines RN Drug Metab Dispos; 2008 Aug; 36(8):1587-93. PubMed ID: 18474679 [TBL] [Abstract][Full Text] [Related]
17. Taurine concentration in the brain and in the plasma following intraperitoneal injections. Lallemand F; De Witte P Amino Acids; 2004 Mar; 26(2):111-6. PubMed ID: 15042438 [TBL] [Abstract][Full Text] [Related]
18. Identification of CYP2D6 null variants among long-stay, chronic psychiatric inpatients: is it strictly necessary? Fernández-Santander A; Santiago C; Díez-Durán S; González M; de Castro E; Guijarro J; Bandrés F; Lucia A; Gómez-Gallego F Hum Psychopharmacol; 2008 Aug; 23(6):533-6. PubMed ID: 18425996 [TBL] [Abstract][Full Text] [Related]
19. Plasma amino acid and whole blood taurine concentrations in cats eating commercially prepared diets. Heinze CR; Larsen JA; Kass PH; Fascetti AJ Am J Vet Res; 2009 Nov; 70(11):1374-82. PubMed ID: 19878020 [TBL] [Abstract][Full Text] [Related]
20. Effects of the CYP2D6*10 alleles and co-medication with CYP2D6-dependent drugs on risperidone metabolism in patients with schizophrenia. Yagihashi T; Mizuno M; Chino B; Sato Y; Sakuma K; Takebayashi T; Takao T; Kosaki K Hum Psychopharmacol; 2009 Jun; 24(4):301-8. PubMed ID: 19387994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]